KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Amortization - Intangibles (2016 - 2025)

Historic Amortization - Intangibles for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to $168.4 million.

  • Jazz Pharmaceuticals' Amortization - Intangibles rose 692.95% to $168.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $646.8 million, marking a year-over-year increase of 433.38%. This contributed to the annual value of $627.3 million for FY2024, which is 312.83% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Amortization - Intangibles of $168.4 million as of Q3 2025, which was up 692.95% from $162.1 million recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Amortization - Intangibles peaked at $172.1 million during Q1 2022, and registered a low of $68.2 million during Q1 2021.
  • In the last 5 years, Jazz Pharmaceuticals' Amortization - Intangibles had a median value of $155.1 million in 2023 and averaged $149.5 million.
  • In the last 5 years, Jazz Pharmaceuticals' Amortization - Intangibles soared by 15236.68% in 2022 and then crashed by 1296.27% in 2023.
  • Quarter analysis of 5 years shows Jazz Pharmaceuticals' Amortization - Intangibles stood at $157.3 million in 2021, then fell by 12.66% to $137.4 million in 2022, then rose by 10.31% to $151.6 million in 2023, then rose by 4.85% to $158.9 million in 2024, then rose by 5.96% to $168.4 million in 2025.
  • Its Amortization - Intangibles stands at $168.4 million for Q3 2025, versus $162.1 million for Q2 2025 and $158.9 million for Q4 2024.